These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24633743)

  • 21. 'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid Leukemia.
    Brumatti G; Lalaoui N; Wei AH; Silke J
    Trends Mol Med; 2017 Mar; 23(3):264-281. PubMed ID: 28196625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.
    Luskin MR; DeAngelo DJ
    Expert Rev Hematol; 2017 Dec; 10(12):1033-1045. PubMed ID: 29069942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia.
    Zeidner JF; Karp JE
    Leuk Res; 2015 Dec; 39(12):1312-8. PubMed ID: 26521988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in targeted therapy for acute myeloid leukaemia.
    Kayser S; Levis MJ
    Br J Haematol; 2018 Feb; 180(4):484-500. PubMed ID: 29193012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatment for acute myelogenous leukemia.
    DiNardo CD; Cortes JE
    Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy.
    Foran JM
    Hematology; 2012 Apr; 17 Suppl 1():S137-40. PubMed ID: 22507802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
    Huang LW; Olin RL
    J Geriatr Oncol; 2017 Nov; 8(6):417-420. PubMed ID: 28835351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.
    Thomas D; Powell JA; Vergez F; Segal DH; Nguyen NY; Baker A; Teh TC; Barry EF; Sarry JE; Lee EM; Nero TL; Jabbour AM; Pomilio G; Green BD; Manenti S; Glaser SP; Parker MW; Lopez AF; Ekert PG; Lock RB; Huang DC; Nilsson SK; Récher C; Wei AH; Guthridge MA
    Blood; 2013 Aug; 122(5):738-48. PubMed ID: 23775716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel drugs for older patients with acute myeloid leukemia.
    Montalban-Bravo G; Garcia-Manero G
    Leukemia; 2015 Apr; 29(4):760-9. PubMed ID: 25142817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia.
    Gebru MT; Wang HG
    J Hematol Oncol; 2020 Nov; 13(1):155. PubMed ID: 33213500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Laing AA; Harrison CJ; Gibson BES; Keeshan K
    Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Therapies in Acute Myeloid Leukemia.
    Mukherjee S; Sekeres MA
    Semin Oncol Nurs; 2019 Dec; 35(6):150955. PubMed ID: 31759818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of primary refractory acute myeloid leukemia in the era of targeted therapies.
    McMahon CM; Perl AE
    Leuk Lymphoma; 2019 Mar; 60(3):583-597. PubMed ID: 30234399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance.
    Grunwald MR; Levis MJ
    Int J Hematol; 2013 Jun; 97(6):683-94. PubMed ID: 23613268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research Advances on Targeted Therapy for Acute Myeloid Leukemia--Review].
    He HT; Li HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):245-9. PubMed ID: 26913430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordinate PI3K pathway and Bcl-2 family disruption in AML.
    Bose P; Rahmani M; Grant S
    Oncotarget; 2012 Dec; 3(12):1499-500. PubMed ID: 23439314
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
    Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
    Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute myeloid leukemia].
    Döhner K; Paschka P; Döhner H
    Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody Based Therapies in Acute Leukemia.
    Shah NN
    Curr Drug Targets; 2017; 18(3):257-270. PubMed ID: 27593687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.